These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 17027567)

  • 21. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
    Kelbaek H; Kløvgaard L; Helqvist S; Lassen JF; Krusell LR; Engstrøm T; Bøtker HE; Jørgensen E; Saunamäki K; Aljabbari S; Thayssen P; Galløe A; Jensen GV; Thuesen L
    J Am Coll Cardiol; 2008 May; 51(21):2011-6. PubMed ID: 18498953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
    Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
    Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
    Morice MC; Serruys PW; Barragan P; Bode C; Van Es GA; Stoll HP; Snead D; Mauri L; Cutlip DE; Sousa E
    J Am Coll Cardiol; 2007 Oct; 50(14):1299-304. PubMed ID: 17903626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
    Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
    Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
    Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C
    Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial.
    Serruys PW; Degertekin M; Tanabe K; Abizaid A; Sousa JE; Colombo A; Guagliumi G; Wijns W; Lindeboom WK; Ligthart J; de Feyter PJ; Morice MC;
    Circulation; 2002 Aug; 106(7):798-803. PubMed ID: 12176950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study.
    Tomai F; Reimers B; De Luca L; Galassi AR; Gaspardone A; Ghini AS; Ferrero V; Favero L; Gioffrè G; Prati F; Tamburino C; Ribichini F
    Diabetes Care; 2008 Jan; 31(1):15-9. PubMed ID: 17909090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice.
    Cosgrave J; Melzi G; Corbett S; Biondi-Zoccai GG; Agostoni P; Babic R; Airoldi F; Chieffo A; Sangiorgi GM; Montorfano M; Michev I; Carlino M; Colombo A
    J Am Coll Cardiol; 2007 Jun; 49(24):2320-8. PubMed ID: 17572247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis.
    Kim YH; Lee BK; Park DW; Park KH; Choi BR; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Dec; 98(11):1451-4. PubMed ID: 17126648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravascular ultrasound study of the effect of beta-emitting ((55)Co) stents on vascular remodeling and intimal proliferation.
    Cervinka P; Stásek J; Costa MA; Stursa J; Fiser M; Vodnanský P; Kocisová M; Veselka J; Pleskot M; Malý J
    Catheter Cardiovasc Interv; 2004 Mar; 61(3):320-5. PubMed ID: 14988888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries.
    Tanimoto S; Daemen J; Tsuchida K; García-García HM; de Jaegere P; van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):94-103. PubMed ID: 17139687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent implantation of sirolimus- and paclitaxel-eluting stents in the same vessel.
    Corbett SJ; Cosgrave J; Colombo A
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):109-14. PubMed ID: 17139626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial greyscale and radiofrequency intravascular ultrasound assessment of plaque modification and vessel geometry at proximal and distal edges of bare metal and first-generation drug-eluting stents.
    Ribamar Costa J; Abizaid A; Sousa A; Siqueira D; Chamié D; Feres F; Costa R; Staico R; Maldonado G; Centemero M; Tanajura LF; Viana R; Chaves Á; Abizaid A; Sousa JE
    EuroIntervention; 2012 Jun; 8(2):225-34. PubMed ID: 22717925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial).
    Sakurai R; Ako J; Morino Y; Sonoda S; Kaneda H; Terashima M; Hassan AH; Leon MB; Moses JW; Popma JJ; Bonneau HN; Yock PG; Fitzgerald PJ; Honda Y;
    Am J Cardiol; 2005 Nov; 96(9):1251-3. PubMed ID: 16253592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial change and its determinants of residual plaque characteristics under sirolimus-eluting stent: a coronary angioscopic study.
    Kanai T; Hiro T; Takayama T; Watanabe Y; Fukamachi D; Kitano D; Kawano T; Hirayama A
    J Cardiol; 2012 Oct; 60(4):270-6. PubMed ID: 22819742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation.
    Takebayashi H; Kobayashi Y; Mintz GS; Carlier SG; Fujii K; Yasuda T; Moussa I; Mehran R; Dangas GD; Collins MB; Kreps E; Lansky AJ; Stone GW; Leon MB; Moses JW
    Am J Cardiol; 2005 Feb; 95(4):498-502. PubMed ID: 15695138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation between preintervention remodeling and late arterial responses to coronary angioplasty or atherectomy.
    Mintz GS; Kimura T; Nobuyoshi M; Dangas G; Leon MB
    Am J Cardiol; 2001 Feb; 87(4):392-6. PubMed ID: 11179520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usual dose of simvastatin does not inhibit plaque progression and lumen loss at the peri-stent reference segments after bare-metal stent implantation: a serial intravascular ultrasound analysis.
    Hong YJ; Jeong MH; Choi YH; Ma EH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Korean J Intern Med; 2010 Dec; 25(4):356-63. PubMed ID: 21179272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of edge effects with paclitaxel-eluting stents using serial intravascular ultrasound radiofrequency data analysis: the BETAX (BEside TAXus) Study.
    García-García HM; Gonzalo N; Tanimoto S; Meliga E; de Jaegere P; Serruys PW
    Rev Esp Cardiol; 2008 Oct; 61(10):1013-9. PubMed ID: 18817677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.